Wolters Kluwer completed the acquisition of Invistics Corporation, a provider of cloud-based, AI-enabled software for drug diversion detection and controlled substance compliance. Invistics is now part of the company’s Clinical Surveillance, Compliance & Data Solutions unit, part of Clinical Solutions. For more information, please visit us on our company website www.Invistics.com or call 770-559-6386.